MedTrace Logo

Assessment of Renal Microcirculation With Rubidium Positron Emission Tomography

NCT06332456 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2025-07-29

No results posted yet for this study

Summary

The aim of this study is to demonstrate that positron emission tomography imaging with Rubidium-82 (radioactive tracer) can non-invasively detect and quantify changes in renal blood flow (renal perfusion) and renal vascular resistance in both healthy subjects and patients with renal insufficiency. Ultimately, the results of this study will contribute to a better understanding of the role of positron emission imaging in the evaluation of patients with renal diseases.

Conditions

  • Renal Microcirculation With Rubidium Positron Emission Tomography

Sponsors & Collaborators

  • Matthieu Pelletier-Galarneau, MD MSc

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-07-04
Primary Completion
2024-11-21
Completion
2024-11-22

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06332456 on ClinicalTrials.gov